Barrington Research Maintains Outperform on Dentsply Sirona, Maintains $41 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an Outperform rating on Dentsply Sirona (XRAY) and kept the price target at $41. This reaffirms the firm's positive outlook on the stock.

April 18, 2024 | 1:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research's continued Outperform rating and $41 price target on Dentsply Sirona indicates a strong confidence in the company's future performance.
The reaffirmation of an Outperform rating and a specific price target suggests that Barrington Research sees continued potential in Dentsply Sirona's stock, likely due to the company's solid fundamentals or growth prospects. This could positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100